first large study of glp 1 receptor agonists during pregnancy Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Use of GLP1 receptor agonists
Description
Use of this blog's information is at your own risk

GLP-1RAs are a relatively new class of injectables that are effective at reducing HbA 1c , have a low risk of hypoglycaemia when given as monotherapy or in the absence of sulphonylureas (SU) or insulin, and have the potential for weight losskey considerations when treating a typical obese patient with T2DM [4]
Traussnigg, S
Neves JS, Packer M, Ferreira JP

They also slow down the movement of food through the stomach and curb appetite, thereby causing weight loss

10.1038/ajg.2010.363 56
